Table 1. The main characteristics of included studies.
| Author (Year) | Country | miRNA | miRNA expression | FIGO stage | Histology | Lymph node metastasis | Sample type | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| low | high | early | advanced | Squamous | Non-squamous | No | Yes | ||||
|
S.Azizmohammadi (2016) |
Iran | miRNA-145 | 18 | 17 | 20 | 15 | unknown | unknown | 21 | 14 | snap-frozen tissue |
| Fan (2015) | China | miRNA-125a | 30 | 25 | 26 | 29 | 50 | 5 | 26 | 29 | snap-frozen tissue |
| Wang (2015) | China | miRNA-145 | 63 | 51 | 58 | 56 | 114 | 0 | 43 | 71 | snap-frozen tissue |
| Liu (2015) | China | miRNA-196a | 67 | 38 | 74 | 31 | 84 | 21 | 68 | 37 | serum |
| Hou (2013) | China | miRNA-196a | 46 | 46 | 88 | 4 | unknown | unknown | 81 | 11 | snap-frozen tissue |
| Huang (2012) | China | miRNA-125b | 40 | 4 | 36 | 8 | 0 | 44 (SCCC) | 30 | 14 | FFPE |
| Huang (2012) | China | miRNA-145 | 18 | 26 | 36 | 8 | 0 | 44 (SCCC) | 30 | 14 | FFPE |
FFPE: formalin-fixed paraffin embedded; SCCC: neuroendocrine small cell cervical carcinoma; FIGO: International Federation of Gynecology and Obstetrics; early: FIGO stage IA-IIA, advanced : FIGO stage IIB–IV.